MENU
+Compare
PYPD
Stock ticker: NASDAQ
AS OF
Jul 25 closing price
Price
$3.68
Change
-$0.06 (-1.60%)
Capitalization
37.5M

PYPD PolyPid Ltd Forecast, Technical & Fundamental Analysis

PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology... Show more

PYPD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for PYPD with price predictions
Jul 25, 2025

PYPD sees its 50-day moving average cross bullishly above its 200-day moving average

The 50-day moving average for PYPD moved above the 200-day moving average on July 09, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 16, 2025. You may want to consider a long position or call options on PYPD as a result. In of 120 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for PYPD just turned positive on July 17, 2025. Looking at past instances where PYPD's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where PYPD advanced for three days, in of 197 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 60 cases where PYPD Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for PYPD moved out of overbought territory on June 17, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 9 similar instances where the indicator moved out of overbought territory. In of the 9 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 43 cases where PYPD's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PYPD declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

PYPD broke above its upper Bollinger Band on July 16, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. PYPD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: PYPD's P/B Ratio (434.783) is very high in comparison to the industry average of (18.028). P/E Ratio (0.000) is within average values for comparable stocks, (59.593). PYPD's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.512). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (278.844).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PYPD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
PYPD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

PYPD is expected to report earnings to fall 18.93% to -56 cents per share on August 06

PolyPid Ltd PYPD Stock Earnings Reports
Q2'25
Est.
$-0.57
Q1'25
Beat
by $0.22
Q4'24
Missed
by $0.22
Q3'24
Missed
by $0.22
Q2'24
Beat
by $0.05
The last earnings report on May 14 showed earnings per share of -69 cents, beating the estimate of -92 cents. With 23.54K shares outstanding, the current market capitalization sits at 37.50M.
A.I. Advisor
published General Information

General Information

a clinical stage biopharmaceutical company focusing on the development, manufacture, and commercialization of administered therapies to improve surgical outcomes

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
18 Hasivim Street
Phone
+972 747195700
Employees
62
Web
https://www.polypid.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
STLA10.130.55
+5.74%
Stellantis NV
FDP35.630.37
+1.05%
Fresh Del Monte Produce
RITM12.19-0.04
-0.33%
Rithm Capital Corp
JBIO8.28-0.05
-0.60%
Jade Biosciences Inc
AGMH2.45-0.02
-0.81%
AGM Group Holdings Inc

PYPD and Stocks

Correlation & Price change

A.I.dvisor tells us that PYPD and ELEV have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PYPD and ELEV's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PYPD
1D Price
Change %
PYPD100%
-1.60%
ELEV - PYPD
30%
Poorly correlated
N/A
MESO - PYPD
29%
Poorly correlated
-3.65%
PRTA - PYPD
26%
Poorly correlated
-0.30%
ASPHF - PYPD
24%
Poorly correlated
N/A
TENX - PYPD
23%
Poorly correlated
-0.98%
More